QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference

Rhea-AI Summary

QuidelOrtho (NASDAQ: QDEL), a global provider of in vitro diagnostic technologies, announced its participation in the upcoming Baird 2025 Global Healthcare Conference. The company's management team will engage in a fireside chat on September 10, 2025, at 3:10 p.m. ET.

Investors and interested parties can access the live webcast and replay through QuidelOrtho's investor relations website. The company specializes in diagnostic solutions for point-of-care settings, clinical laboratories, and transfusion medicine.

News Market Reaction – QDEL

+0.83%

2 alerts

+0.83% Session close to close

$1.98B Market Cap

0.3x Rel. Volume

In the Aug 28 session, QDEL gained 0.83%, reflecting a mild positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team will participate in the Baird 2025 Global Healthcare Conference on Wednesday, September 10, 2025. The Company's fireside chat will begin at 3:10 p.m. ET / 12:10 p.m. PT.

Interested parties can access the live webcast and replay in the "Events & Presentations" section of the "Investor Relations" page of QuidelOrtho's website at https://ir.quidelortho.com.

QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.

About QuidelOrtho Corporation

QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent in vitro diagnostics solutions that transform data into understanding and action for more people in more places every day. 

By offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, QuidelOrtho brings fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic.

Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.

Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@quidelortho.com 

Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@quidelortho.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-participate-in-the-baird-2025-global-healthcare-conference-302540601.html

SOURCE QuidelOrtho Corporation

FAQ

When is QuidelOrtho (QDEL) presenting at the Baird 2025 Global Healthcare Conference?

QuidelOrtho will present at the conference on Wednesday, September 10, 2025 at 3:10 p.m. ET / 12:10 p.m. PT.

How can investors access QuidelOrtho's (QDEL) presentation at the Baird conference?

Investors can access the live webcast and replay through the 'Events & Presentations' section of QuidelOrtho's investor relations website at ir.quidelortho.com.

What type of products does QuidelOrtho (QDEL) specialize in?

QuidelOrtho specializes in innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs, and transfusion medicine.

What format will QuidelOrtho's (QDEL) presentation take at the Baird Healthcare Conference?

QuidelOrtho's presentation will be in a fireside chat format with members of the management team.